Burlingame, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Global Menopause Treatment Market size is projected to grow from USD 15.21 billion in 2023 to USD 24.33 billion by 2031, at a CAGR of 5.9%, as per the recent study by Coherent Market Insights. Increasing awareness about menopause symptoms and treatment, the demand for effective menopause treatment products and drugs has increased significantly over the past few decades. This has encouraged pharmaceutical companies to invest heavily in R&D in order to develop more innovative and effective menopausal treatment products. Products such as new bioidentical hormones, herbal supplements and alternative treatment methods have emerged, offering effective symptom relief with minimal or no side effects.
Get Sample Pages: https://www.coherentmarketinsights.com/insight/request-sample/6676
Market Dynamics:
The Global Menopause Treatment Market is driven by the rising prevalence of early menopause among women globally. Early menopause refers to menopause occurring under the age of 40 naturally or due to medical interventions such as surgery. According to the World Health Organization (WHO), around 1% of women experience early or premature menopause. Furthermore, lifestyle changes such as rising stress levels, unhealthy diets, and excessive smoking are contributing to the incidence of early menopause. This has raised the demand for effective menopause treatment options across the world.
Global Menopause Treatment Market Report Coverage
| Report Coverage | Details |
| Market Revenue in 2024 | $15.21 million |
| Estimated Value by 2031 | $24.33 million |
| Growth Rate | Poised to grow at a CAGR of 5.9% |
| Historical Data | 2019–2023 |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Million/Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Treatment Type, By Route of Administration, By Form, By Indication, By Distribution Channel |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of World |
| Growth Drivers | • Increasing Geriatric population • Growing Awareness and Conversation around Menopause |
| Restraints & Challenges | • Side effects of HRT drugs • High cost of Treatment |
Market Trends:
Hormone therapy remains the most favored treatment option: Hormone therapy (HT) involving estrogen and progesterone (combined HT) or estrogen-only therapy continues to be the most effective treatment prescribed by doctors worldwide for managing various symptoms related to menopause. According to a survey, over 60% of women experiencing severe menopause symptoms opt for HT.
Herbal supplements gaining traction: With rising consumer preference for natural remedies over pharmaceutical drugs, the demand for herbal supplements for menopause relief is growing significantly. Some of the most popular herbal supplements used include red clover, black cohosh, and Macafem among others. Their widespread availability in the form of capsules and tablets has further boosted their adoption.
Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6676
Estrogen replacement therapy (ERT) is the most common treatment option for managing menopause symptoms. It involves the use of exogenous estrogens like conjugated estrogens or synthetic estrogens like estradiol to replace the drop in endogenous estrogen levels during menopause. ERT helps reduce hot flashes, night sweats, and vaginal dryness, among other symptoms. It is typically prescribed as pills, skin patches, gels or creams. The hormone therapy segment is expected to hold the largest share of the menopause treatment market due to the effectiveness of ERT in managing climacteric symptoms. Within the segment, the estrogen receptor agonist/antagonist therapy sub-segment is anticipated to dominate during the forecast period.
Non-hormonal therapies provide an alternative for women who cannot or choose not to take hormone therapy. This treatment segment includes the use of anti-depressants, anti-seizure medications, and herbal/botanical remedies. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly prescribed non-hormonal therapies as they help lower hot flash frequency and severity. Herbal supplements containing black cohosh and red clover are also gaining popularity. The non-hormonal therapy segment is projected to grow at a high CAGR during 2024-2031 owing to the rising demand for non-estrogen menopause treatments.
Key Market Takeaways:
The global menopause treatment market is anticipated to witness a CAGR of 5.9% during the forecast period 2024-2031, owing to the growing awareness about menopausal health and therapies.
On the basis of treatment type, the hormone therapy segment, especially estrogen receptor agonist/antagonist therapy, is expected to hold a dominant position due to widespread acceptance.
On the basis of route of administration, the oral segment dominates due to ease of use. North America is expected to hold a dominant position over the forecast period, due to high healthcare expenditure and awareness levels in the region.
Key players operating in the menopause treatment market include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd., AbbVive Inc., Nono Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck &Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organin, SnapNurse, Glenmark Pharmaceuticals limited, Procter & Gamble, Duckesnay USA, TherapeutoicsMD., Inc. These players are focused on developing advanced treatment solutions.
Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/6676
Recent Developments:
In September 2023, LifeMD, Inc., announced a partnership with ASCEND Therapeutics Inc.
In August 2020, Bayer AG, announced the acquisition of KaNDy Therapeutics Ltd, to expand the company’s drug development pipeline in women’s healthcare.
Market Segmentation:
By Treatment Type:
- Hormone Therapy
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
- Non-hormonal Therapy
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
- Others
By Route of Administration:
- Oral
- Topical
- Parenteral
- Vaginal
- Others
By Form:
- Tablets
- Creams
- Patches
- Pessaries
- Injections
- Others
By Indication:
- Perimenopause
- Menopause
- Postmenopause
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Specialty Stores
- Others
By Region:
North America:
- U.S.
- Canada
Latin America:
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe:
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East:
- GCC Countries
- Israel
- Rest of Middle East
Africa:
- South Africa
- North Africa
- Central Africa
Browse Related Reports:
Cold Sore Treatment Market, By Product Type (Topical Treatments, Oral Treatments, Light-Based Treatments), By Cold Sore Type (Primary Outbreaks and Recurrent Outbreaks), By Age Group (Children and Adolescents and Adults), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)
Bronchitis Treatment Market, By Type (Acute Bronchitis and Chronic Bronchitis), By Treatment (Drugs and Oxygen Therapy), By Drug Class (Anti-Inflammatory Drugs, Antibiotics, Bronchodilators, Mucolytic), By Route of Administration (Oral, Parenteral, Inhalers/Nasal sprays, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)
Dyspareunia Treatment Market, By Drug Type (Selective Estrogen Receptor Modulators, Estrogens (Miscellaneous Vaginal Agents), Corticosteroids, Antibiotics, and Others), By Route of Administration (Oral, Vaginal Inserts, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-commerce, and Others), By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)
Severs Disease Treatment Market, By Disease Type (Acute, Chronic), By Drug (Diclofenac, Etodolac, Indomethacin, Celecoxib, Others), By Application (Over-the-counter, Prescription), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography, Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)
Author Bio:
Money Singh is a seasoned PR writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
(LinkedIn: https://www.linkedin.com/in/money-singh-590844163)
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
